Method of reducing the risk of adverse cardiovascular (CV) events associated with the administration of pharmaceutical agents which favor CV events

Details for Australian Patent Application No. 2006280358 (hide)

Owner Hellstrom, H.

Inventors Hellstrom, Harold Richard

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006280358

PCT Pub. Number WO2007/021460

Priority 60/735,277 11.11.05 US; 60/708,728 15.08.05 US; 60/782,594 14.03.06 US; 11/489,996 20.07.06 US; 60/801,790 19.05.06 US

Filing date 21 July 2006

Wipo publication date 22 February 2007

Acceptance publication date 8 December 2011

International Classifications

A61K 31/33 (2006.01) - Heterocyclic compounds

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2007/021460 Priority application(s): WO2007/021460

8 December 2011 Application Accepted

  Published as AU-B-2006280358

5 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006280398-Ophthalmic injector system

2006280352-Partial item change tracking and synchronization